Pembro Plus Chemo: Practice-Changing for Nonsquamous mNSCLC Pembro Plus Chemo: Practice-Changing for Nonsquamous mNSCLC

Adding pembrolizumab to chemotherapy provided significant improvement in both overall and progression-free survival; the results have been hailed as practice-changing.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news